Dan Spiegelman

Montreal Neurological Institute and Hospital

Also affiliated with Washington University in St. Louis, McGill University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study”.

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Journal of Clinical Investigation(2024)10.1172/jci180916

N/A

0.332DataRank · unranked

8 citations

Dan Spiegelman, Prethy Rao, Andria L. Ford, Jonathan J. Miner, Rajendra S. Apte +1 more

Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers

Molecular Neurobiology(2025)10.1007/s12035-025-04996-1

N/A

0.208DataRank · unranked

3 citations

Lynne Krohn, Konstantin Senkevich, Eric Yu, Jamil Ahmad, Farnaz Asayesh +8 more

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease

medRxiv(2022)10.1101/2022.04.30.22274239

N/A

0DataRank · unranked

3 citations

Cornelia E. Zorca, Aliza Dworkind, Uladzislau Rudakou, Emma N. Somerville, Eric Yu +24 more

Association of Rare Variants in ARSA with Parkinson's Disease

Movement Disorders(2023)10.1002/mds.29521

N/A

0DataRank · unranked

14 citations

Mariia Beletskaia, Aliza Dworkind, Eric Yu, Jamil Ahmad, Jennifer A. Ruskey +20 more

Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03433-3

N/A

0DataRank · unranked

9 citations

Dan Spiegelman, Mildred Felder, Arika S. Feils, Noah Tsarovsky, Jen Zaborek +5 more

Generation of Novel Immunocompetent Mouse Cell Lines to Model Experimental Metastasis of High-Risk Neuroblastoma

Cancers(2023)10.3390/cancers15194693

N/A

0DataRank · unranked

2 citations

Dan Spiegelman, Lisa Schneper, Amy K. Erbe, Paul M. Sondel, Vladimir S. Spiegelman +1 more

Association of rare variants in ARSA with Parkinson’s disease

medRxiv(2023)10.1101/2023.03.08.23286773

N/A

0DataRank · unranked

4 citations

Mariia Beletskaia, Aliza Dworkind, Eric Yu, Jamil Ahmad, Jennifer A. Ruskey +19 more

HLA in isolated REM sleep behavior disorder and Lewy body dementia

medRxiv(2023)10.1101/2023.01.31.23284682

N/A

0DataRank · unranked

1 citations

Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Dan Spiegelman, Zalak Shah +38 more

Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease?

npj Parkinson s Disease(2024)10.1038/s41531-024-00809-9

N/A

0DataRank · unranked

3 citations

Sitki Cem Parlar, Cloe Chantereault, Eric Yu, Jamil Ahmad, Jennifer A. Ruskey +15 more

Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002715

N/A

0DataRank · unranked

30 citations

Alexander L. Rakhmilevich, Dan Spiegelman, Ravi B. Patel, Jen Birstler, Won Jong Jin +8 more

LRRK2 rare-variant per-domain genetic burden in Parkinson’s Disease: association confined to the kinase domain

npj Parkinson s Disease(2025)10.1038/s41531-025-00934-z

N/A

0DataRank · unranked

2 citations

Konstantin Senkevich, Eric Yu, Jennifer A. Ruskey, Jamil Ahmad, Farnaz Asayesh +16 more

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease

Brain(2022)10.1093/brain/awac413

N/A

0DataRank · unranked

39 citations

Cornelia E. Zorca, Aliza Dworkind, Uladzislau Rudakou, Emma N. Somerville, Eric Yu +24 more